reduce basal insulin dose when starting glp-1 receptor agonist Initiation and Titration of in Primary Care: Barriers and Practical Solutions Glucagon-like peptide-1 receptor: mechanisms and
Description
2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Rita Kapoor in Frederick, MD

GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.
Larger randomized controlled trials with long-term follow-up are necessary to confirm these associations and evaluate the risk-benefit ratios

No nausea

For over 30 years, 21st Century Vitamins has provided trusted vitamins and supplements by upholding the highest standards of quality in every product we offer
